Colorectal Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Colorectal Cancer stocks.

Colorectal Cancer Stocks Recent News

Date Stock Title
Apr 24 EXAS Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note
Apr 24 REGN Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Apr 24 REGN Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Apr 24 MYGN Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
Apr 24 SNY What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Apr 24 EXAS Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)
Apr 23 SNY Sanofi reportedly lining up banks for consumer products spinoff
Apr 23 SNY Sanofi Asks Banks to Pitch for $20 Billion OTC Spinoff
Apr 23 SNY Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
Apr 23 SNY Sanofi succeeds in late-stage trial for blood disorder candidate
Apr 23 SNY Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Apr 22 REGN Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Apr 22 EXAS Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
Apr 22 SNY Sanofi reportedly settles 4K Zantac cases for $100M
Apr 22 SNY Market Chatter: Sanofi to Pay More Than $100 Million to Settle 4,000 Suits Alleging Zantac Causes Cancer
Apr 22 EXAS 10 Best Performing Biotech ETFs in 2024
Apr 22 REGN Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
Apr 21 SNY Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
Apr 18 SNY Sanofi to overhaul US operations of vaccines, cut jobs
Colorectal Cancer

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time.Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Some risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. Another risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited genetic disorders that can cause colorectal cancer include familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous.Bowel cancer may be diagnosed by obtaining a sample of the colon during a sigmoidoscopy or colonoscopy. This is then followed by medical imaging to determine if the disease has spread. Screening is effective for preventing and decreasing deaths from colorectal cancer. Screening, by one of a number of methods, is recommended starting from the age of 50 to 75. During colonoscopy, small polyps may be removed if found. If a large polyp or tumor is found, a biopsy may be performed to check if it is cancerous. Aspirin and other non-steroidal anti-inflammatory drugs decrease the risk. Their general use is not recommended for this purpose, however, due to side effects.Treatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy and targeted therapy. Cancers that are confined within the wall of the colon may be curable with surgery, while cancer that has spread widely are usually not curable, with management being directed towards improving quality of life and symptoms. The five-year survival rate in the United States is around 65%. The individual likelihood of survival depends on how advanced the cancer is, whether or not all the cancer can be removed with surgery and the person's overall health. Globally, colorectal cancer is the third most common type of cancer, making up about 10% of all cases. In 2012, there were 1.4 million new cases and 694,000 deaths from the disease. It is more common in developed countries, where more than 65% of cases are found. It is less common in women than men.

Browse All Tags